University Hospital, Grenoble
Clinical trials sponsored by University Hospital, Grenoble, explained in plain language.
-
New drug combo shows promise for untreatable liver cancer
Disease control OngoingThis early-phase study tests whether adding an experimental drug called NP137 to the standard two-drug therapy (Atezolizumab and Bevacizumab) is safe and effective for people with advanced liver cancer that cannot be removed by surgery. About 43 adults who have not had prior syst…
Phase: PHASE1 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New 3D-Guided radiation boost aims to hit prostate tumors more precisely
Disease control OngoingThis small study tests whether a 3D ultrasound system can help doctors place extra radioactive iodine seeds precisely into prostate tumors. Fifteen men with low- or intermediate-risk prostate cancer will receive the boost during standard brachytherapy. The main goal is to see if …
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Exercise program aims to keep kids with cancer moving
Symptom relief OngoingThis study tests whether children and teens with cancer will stick with a personalized exercise program during their treatment. About 38 participants will be offered adapted physical activity sessions from diagnosis or relapse. Researchers will use questionnaires to find out what…
Sponsor: University Hospital, Grenoble • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Ultrasound may let mild head injury patients skip hospital stay
Knowledge-focused OngoingThis study looks at whether a simple ultrasound of the brain's blood flow can safely identify mild traumatic brain injury patients who can go home right away instead of staying in the hospital for observation. About 550 adults with mild head injuries will be randomly assigned to …
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC